Article
Germline modifiers of the tumor immune microenvironment implicate drivers of cancer risk and immunotherapy response
12 May 2023
Abstract excerpt
With the continued promise of immunotherapy for treating cancer, understanding how host genetics contributes to the tumor immune microenvironment (TIME) is essential to tailoring cancer screening and treatment strategies. Here, we study 1084 eQTLs affecting the TIME found through analysis of The Cancer Genome Atlas and literature curation. These TIME eQTLs are enriched in areas of active transcription, and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
